Syenex

Evanston, IL · Founded 2022 · Privately Held (backing)

Developer of bioengineering technologies designed to improve the precision and effectiveness of therapeutic cell engineering. Syenex is based in Evanston, IL and was founded in 2022. It was valued at $22 million at its seed round in Jan 2025, the last priced event on record. It has raised $13.7 million across 2 recorded rounds; the latest was an $8.7 million early-stage round in Jan 2025.

PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$13.7M
Last round
Early Stage VC
Jan 2025

Who backs Syenex?

9 investors
InvestorType
MedTech InnovatorOther
AlleyCorpVenture capital
Lightbank (Venture Capital)Venture capital
Constellation Technology Ventures—
KdT Ventures—
N.XT—
Northwestern University—
The Querrey InQbation Lab—
Walder Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Syenex investors

9 investors are on record for Syenex, including MedTech Innovator, AlleyCorp, Lightbank (Venture Capital) and Constellation Technology Ventures. The early-stage round in Jan 2025 drew 18 investors.

Free account
More of Syenex with a free account
  • ·Watch Syenex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Syenex. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View